Adhesion Barrier Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Synthetic Adhesion Barrier, Natural Adhesion Barrier), By Formulation (Film, Liquid and Gel), By Application (Orthopedic Surgeries, Urological Surgeries, Gynecological Surgeries, Cardiovascular Surgeries, Reconstructive Surgeries, Neurological Surgeries, Abdominal Surgeries and Others) By End User (Hospitals, Clinics and Ambulatory Surgical Centers), and Region Forecast 2020-2031

Adhesion Barrier Market size was valued at US$ 1,007.4 million in 2024 and is expected to reach US$ 1,783.3 million by 2031, growing at a significant CAGR of 8.5% from 2025-2031. An adhesion barrier is a medical device used to avoid adhesion occurring during surgery. The adhesion barrier reduces abnormal internal scarring by separating organs and internal tissues. The formation of adhesion causes infertility, chronic pain, and bowel obstruction. These barriers are prepared from natural or synthetic sources and the applications include gynecological and abdominal. Cardiovascular, orthopedic, urological, and reconstructive surgeries. The expansion of this market is being fueled by an increase in the number of surgeries and sports-related injuries, as well as an increase in the geriatric population and increased awareness of adhesion formation and adhesion-related disorders. However, due to the COVID-19 pandemic, this market is currently experiencing a slight slowdown in growth due to a decrease in the number of surgical procedures performed to protect patients.

However, as the global economy returns to normal, the number of surgical treatments on hold will gradually increase. Despite the concerns, surgeons are hesitant to utilize adhesion barriers due to a lack of/limited solid clinical evidence confirming the safety and efficacy of commercialized adhesion barrier solutions. Companies also have a hard time getting marketing authorization for their products due to concerns about the safety and efficacy of adhesion barriers. In addition, due to poor clinical outcomes, licensed adhesion barrier treatments have been phased out of the market in recent years. New adhesion barriers necessitate significant expenditure and new products typically take more than 7-8 years to get marketing approval. The cost and time it takes for a product to undergo clinical trials and then pass those studies is quite high, with only a small possibility of the product receiving approval.